SCHEMBL6274094

SCHEMBL6274094

CC(C)=CCCC(C)=CCc1c(O)cc(O)cc1O

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 6/20 0.80
APP P05067 2/20 0.80
PTPN1 P18031 1/20 0.77
BACE1 P56817 1/20 0.77
PPARG P37231 8/20 0.69
PPARA Q07869 7/20 0.69
CNR1 P21554 2/20 0.65
CNR2 P34972 2/20 0.65
TRPV1 Q8NER1 2/20 0.65
TRPA1 O75762 1/20 0.65
INHA P05111 1/20 0.65
SLC6A2 P23975 1/20 0.65
HTR2A P28223 1/20 0.65
SLC6A4 P31645 1/20 0.65
OPRM1 P35372 1/20 0.65
SLC6A3 Q01959 1/20 0.65
KCNH2 Q12809 1/20 0.65
TRPM8 Q7Z2W7 1/20 0.65
TRPV3 Q8NET8 1/20 0.65
TRPV4 Q9HBA0 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23888288 1.00 MAOB (0.80) MAOBAPPPTPN1BACE1PPARG
SCHEMBL19846966 0.91 MAOB (0.97) MAOBAPPPTPN1BACE1PPARG
SCHEMBL29452837 0.89 MAOB (1.00) MAOBAPPPTPN1BACE1PPARG
SCHEMBL4567342 0.88 PTPN1 (0.74) MAOBAPPPTPN1BACE1PPARG
SCHEMBL23522862 0.88 PTPN1 (0.97) MAOBAPPPTPN1BACE1PPARG
SCHEMBL19846964 0.88 PTPN1 (0.97) MAOBAPPPTPN1BACE1PPARG
SCHEMBL24075564 0.87 PTPN1 (0.72) MAOBAPPPTPN1BACE1PPARG
SCHEMBL23896873 0.87 PTPN1 (0.72) MAOBAPPPTPN1BACE1PPARG
Grifolin SCHEMBL21065400 0.87 PTPN1 (1.00) MAOBAPPPTPN1BACE1PPARG
Grifolin SCHEMBL8589594 0.87 PTPN1 (1.00) MAOBAPPPTPN1BACE1PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12606509-B2 Catalytic cannabigerol processes and precursors KARE CHEMICAL TECHNOLOGIES INC. (CA) 2026-04-21 US disclosed
US-20230105720-A1 CATALYTIC CANNABIGEROL PROCESSES AND PRECURSORS KARE CHEMICAL TECHNOLOGIES INC. (CA) 2023-04-06 US disclosed
WO-2021195751-A1 CATALYTIC CANNABIGEROL PROCESSES AND PRECURSORS KARE CHEMICAL TECHNOLOGIES INC. (CA) 2021-10-07 WO disclosed
EP-0994093-B1 POLYHYDROXYPHENOL DERIVATIVES AND PREVENTIVE AND THERAPEUTIC AGENTS FOR BONE AND CARTILAGE DISEASES CONTAINING THE SAME HOECHST MARION ROUSSEL LTD (JP) 2005-12-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230105720-A1 CATALYTIC CANNABIGEROL PROCESSES AND PRECURSORS CNR2, CNR1, MGLL MAOB 1049/4885APP 3853/4885PTPN1 3938/4885
US-12606509-B2 Catalytic cannabigerol processes and precursors CNR2, CNR1, HSD3B2 MAOB 506/4885APP 3411/4885PTPN1 4602/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.